the same time. The serum was separated and stored at 20°C. The mice were supplied by G. L. Bomholtgaard, Dyrlaege, 8680 Ry, Denmark. The cages were placed in a tissue-culture cabinet and the mice were fed Oxoid pellets sterilized by y radiation. The drinking water was not sterilized.
Serum from individual mice was assayed, as described previously. The anti-C. parrum antibody was determined by a modification (Woodruff et al., 1974) of the latex agglutination test of Florman and Scoma (1960) , and immunoglobulin class and subclass levels by the single radial immunodiffusion method of Mancini, Carbonara and Heremans (1965) , the standard serum being calibrated against purified proteins (supplied by Litton Bionetics Inc., Kensington, Maryland, USA). Antibodies cross-reacting with a methylcholanthrene-induced CBA-strain fibrosarcoma were assayed by a modification (James et al., 1976) of the indirect antiglobulin assay of Nossal et al. (1972) .
The results are summarized in Tables I  and II (3-1-3-6)
10-4 (8 -9-10 -9)** 10-9
(9 -9-11 -9)** 2-6 (2 -6-3 -6)
5-6 (3-6-6-1)** 4-6 (4 6-5 6)** c The values expressed are medians with the range in parentheses. d There was considerable variation in IgGI and IgG2a levels in treated and untreated nude mice. In certain instances the immunoglobulin levels were so low they were beyond the sensitivity of the Mancini assay.
The significance of effects was determined by comparing Groups B and C with A, and E and F with D (Wilcoxon Rank Sum Test).
* P < 0-05. ** P < 0-01. All other values were not significantly different from controls.
groups, but these changes were only significant in Group C. (88-180)** the immunoglobulin profile in athymic mice treated with C. parvum, provide further confirmation of the inherent " adjuvanticity" of the organism. The present experiments also establish that the increase in certain Ig levels (and possibly anti-tumourresponses) following C. parvum administration are to some extent independent of T-cell function. These serological observations are important in relation to the known antitumour properties of systemically administered C. parvum in T-deprived and nude mice (Woodruff et al., 1973; Woodruff and Warner, 1977) .
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